Cargando…
Metabolic reprogramming of inner ear cell line HEI-OC1 after dexamethasone application
INTRODUCTION: One approach to dampen the inflammatory reactions resulting from implantation surgery of cochlear implant hearing aids is to embed dexamethasone into the matrix of the electrode carrier. Possible side effects for sensory cells in the inner ear on the metabolomics have not yet been eval...
Autores principales: | Kather, Michel, Koitzsch, Sabine, Breit, Bernhard, Plontke, Stefan, Kammerer, Bernd, Liebau, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144088/ https://www.ncbi.nlm.nih.gov/pubmed/34028607 http://dx.doi.org/10.1007/s11306-021-01799-y |
Ejemplares similares
-
Long-Term in vivo Release Profile of Dexamethasone-Loaded Silicone Rods Implanted Into the Cochlea of Guinea Pigs
por: Liebau, Arne, et al.
Publicado: (2020) -
Inner ear is a target for insulin signaling and insulin resistance: evidence from mice and auditory HEI-OC1 cells
por: Pålbrink, Ann-Ki, et al.
Publicado: (2020) -
Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear
por: Plontke, Stefan K., et al.
Publicado: (2022) -
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear
por: Lehner, Eric, et al.
Publicado: (2021) -
MicroRNA Signature and Cellular Characterization of Undifferentiated and Differentiated House Ear Institute-Organ of Corti 1 (HEI-OC1) Cells
por: Wijesinghe, Printha, et al.
Publicado: (2022)